Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.

ROPIVACAINE KABI ropivacaine hydrochloride 20 mg/10 mL solution for injection ampoule (195796)

ARTG ID 195796

ARTG Name

ROPIVACAINE KABI ropivacaine hydrochloride 20 mg/10 mL solution for injection ampoule

Product name

ROPIVACAINE KABI ropivacaine hydrochloride 20 mg/10 mL solution for injection ampoule

ARTG Date

13 June 2013

Registration Type

Medicine

Therapeutic good type

Medicines

Ingredients

ropivacaine hydrochloride

Licence category

RE

Licence status

A

Summary

Product Information

Consumer Medicine Information

Related information

ROPIVACAINE KABI ropivacaine hydrochloride 20 mg/10 mL solution for injection ampoule, Fresenius Kabi Australia Pty Ltd, CON-747

3 February 2021

Section 14 consent

Consent to Supply while noncompliant with standards. The consent is effective for all batches of the product manufactured from 3 February 2021 until 29 March 2023.
ROPIVACAINE KABI ropivacaine hydrochloride 20 mg/10 mL solution for injection ampoule, Fresenius Kabi Australia Pty Ltd, CON-747

3 February 2021

Section 14 consent

Consent to Supply while noncompliant with standards. The consent is effective for all batches of the product manufactured from 3 February 2021 until 29 March 2023.